Previous 10 | Next 10 |
2023-07-26 06:10:09 ET LivaNova PLC press release ( NASDAQ: LIVN ): Q2 Non-GAAP EPS of $0.78 beats by $0.24 . Revenue of $293.9M (+15.6% Y/Y) beats by $28.86M . Full-Year 2023 Guidance: LivaNova now expects revenue for full-year 2023 to grow between 8% an...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended June 30, 2023 and raised full-year 2023 guidance. Financial Summary and Highlights 1 Second-quarter revenue of $293.9 million increased 15.6% on a reported ...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its second-quarter 2023 results on Wednesday, July 26, 2023 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its second-quarter 2023 results prior t...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the 150th bipolar depression patient has been randomized in the RECOVER clinical study , “A P r ospective, Multi-c e nter, Randomized C ontrolled Blinded Trial Dem o ...
2023-06-12 07:48:17 ET Summary Greenlight Capital's 13F portfolio value increased by around 27% to $1.84B in Q1 2023, with the fund reporting a negative 1.3% return for the quarter. New stakes were established in Black Knight Inc., First Citizens BancShares, and New York Community...
2023-05-11 05:34:13 ET Summary LivaNova hasn't rotated periodic investment capital into incremental market valuation growth for the last 2-3 years. Capital productivity has improved the last few periods, but needs upward mobility to attract investment. Investor funds are at ri...
2023-05-07 11:48:09 ET LivaNova PLC (LIVN) Q1 2023 Earnings Conference Call May 3, 2023 08:00 ET Company Participants Matthew Dodds - Senior Vice President of Corporate Development William Kozy - Chairman & Interim Chief Executive Officer Alex Shvartsburg - C...
2023-05-03 06:14:24 ET LivaNova PLC press release ( NASDAQ: LIVN ): Q1 Non-GAAP EPS of $0.43 beats by $0.04 . Revenue of $263.4M (+9.7% Y/Y) beats by $19.97M . LivaNova now expects revenue for full-year 2023 to grow between 4 and 6 percent on a constant-curre...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended March 31, 2023 and raised full-year 2023 guidance. Financial Summary and Highlights 1 First-quarter revenue of $263.4 million increased 9.7 p...
2023-04-14 17:01:46 ET LivaNova ( NASDAQ: LIVN ) on Friday announced the resignation of its CEO and preliminary Q1 revenue that was above consensus estimates. Damien McDonald resigned as LIVN's CEO, the company said in a statement , with chair of the board William Kozy app...
News, Short Squeeze, Breakout and More Instantly...
2024-06-23 00:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2024 results on Wednesday, July 31, 2024 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its second-quarter 2024 results prior to the call. ...
2024-06-06 11:00:14 ET Rick Wise from Stifel Nicolaus issued a price target of $70.00 for LIVN on 2024-06-06 09:52:00. The adjusted price target was set to $70.00. At the time of the announcement, LIVN was trading at $53.16. The overall price target consensus is at $69.5...